{"id":15477,"date":"2025-11-20T11:39:58","date_gmt":"2025-11-20T06:09:58","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=15477"},"modified":"2025-11-20T11:58:08","modified_gmt":"2025-11-20T06:28:08","slug":"stocks-to-buy-today-november-20-2025","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-november-20-2025\/","title":{"rendered":"Stocks to Buy Today: November 20, 2025"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

The Indian stock market<\/a> extended its upward movement on Wednesday, November 19, 2025. The Nifty 50<\/a> closed 0.55% higher at 26,052.65, while the Sensex<\/a> ended 0.61% higher at 85,186.47. Supported by gains in heavyweight IT and banking names, the total market capitalisation of BSE-listed companies climbed to \u20b9475.6 trillion \u2014 adding nearly \u20b91 trillion in a single session.<\/span><\/p>\n

Against this constructive backd<\/span>rop, here are the three stocks to watch today based on fundamentals, sector momentum, and recent developments:<\/span>\u00a0<\/span><\/p>\n

Indegene Ltd, Nuvoco Vistas Corporation Ltd, and Max Healthcare Institute Ltd.<\/span>\u00a0<\/span><\/p>\n

<\/span>Indegene Ltd [NSE: INDGN]<\/span><\/b>\u00a0<\/span><\/span><\/h2>\n

<\/span>Indegene \u2013 Key Market Data <\/span><\/b>\u00a0<\/span><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/span><\/b>\u00a0<\/span><\/td>\nValue<\/span><\/b>\u00a0<\/span><\/td>\n<\/tr>\n
Previous Close (as of Nov 19, 2025)<\/span>\u00a0<\/span><\/td>\n\u20b9514.70<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Day Range<\/span>\u00a0<\/span><\/td>\n\u20b9512.90 \u2013 \u20b9516.90<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
52-Week Range<\/span>\u00a0<\/span><\/td>\n\u20b9499.00 \u2013 \u20b9694.40<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Market Cap<\/span>\u00a0<\/span><\/td>\n\u20b912.37KCr<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
P\/E Ratio<\/span>\u00a0<\/span><\/td>\n27.76<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Dividend Yield<\/span>\u00a0<\/span><\/td>\n0.39%<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Avg Trading Volume<\/span>\u00a0<\/span><\/td>\n315.89K<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Exchange<\/span>\u00a0<\/span><\/td>\nNSE<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Company Type<\/span>\u00a0<\/span><\/td>\nMid-Cap<\/span> Stock<\/span><\/a><\/td>\n<\/tr>\n
Beta<\/span>\u00a0<\/span><\/td>\n0.75<\/span>\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n


\n\"\"
\n<\/a><\/p>\n

Indegene<\/a> re<\/span>mains a strong pick in the digital healthcare solutions space, supported by 17.1% YoY revenue growth in Q2 FY26 and management\u2019s expectation of full-year growth above 20%. The margin dip last quarter was driven by one-time M&A expenses, with recovery anticipated ahead. With multiple strategic acqui<\/span>sitions expanding its global footprint and a steady pipeline of large deal wins, Indegene stands out a<\/span>s a high-visibility growth stock to track today.<\/span>\u00a0<\/span><\/p>\n